Dear Editor:Despite decimating populations over the centuries, plague is currently an invisible
zoonosis for both the state and society. Human cases of the plague have declined in the
recent years. However, plague has been overlooked in medical education, and hence, most
of the health professionals face difficulties in recognizing the disease symptoms. Such
panorama is concerning since early identification of isolated cases may be the key to
prevent the spread of an epidemic.Brazil has several plague foci, where the agent (Yersinia pestis), its
hosts, and vectors coexist, constituting a permanent threat to the local population and
to those who visit the areas for leisure or work. These focal areas are spreading
throughout the mountains of Ibiapaba and Baturité (State of Ceará) and in Chapada do
Araripe (States of Ceará, Pernambuco, and Piauí), Chapada da Borborema (States of
Alagoas, Paraíba, Pernambuco, and Rio Grande do Norte), Serra de Triunfo (States of
Paraíba and Pernambuco), Plateau Oriental, Chapada Diamantina, Piemonte da Chapada
Diamantina (State of Bahia), Vale do Rio Doce, Vale do Jequitinhonha (State of Minas
Gerais), and Serra dos Orgãos (State of Rio de Janeiro)
.The experience accumulated in Brazil for more than a century shows that notification and
early diagnosis are essential to save the patient’s life, to identify the probable index
case, and to trigger prevention activities to avoid future epidemics. Therefore,
healthcare professionals must understand the regional nosology, which allows them to
identify instances of plague to help confirm the diagnosis.Plague is also an occupational hazard
,
. A serological survey has revealed the presence of antibodies against plague and
hantavirus among healthcare professionals working in zoonosis control programs. However,
they had no previous symptoms or clinical signs of plague
. It is advisable to populations in at-risk areas to be aware of events
suggestive of plague, such as the occurrence of epizootics of rodents without apparent
cause. These signs are not always perceived or valued by healthcare professionals or the
general public.Because of the lack of attention regarding plague control, it is difficult to estimate
the actual plague-associated morbidity and mortality, which is aggravated because this
zoonosis occurs in remote and impoverished places where the populations have limited
access to healthcare services and health surveillance is practically nonexistent.
Therefore, it is reasonable to speculate that cases of the disease occur, but they are
not reported.In contrast, false-positive cases result from misdiagnosis in clinical laboratories that
use automated systems of microbial identification
. Some systems do not correctly identify Y. pestis, leading to a
false-positive or -negative diagnosis. Because of its weak biochemical reactivity,
Y. pestis can be confused for Shigella, Acinetobacter,
Pseudomonas, and even other enteropathogenic and environmental
Yersinia species
,
.Therefore, in the focal areas, the general public, healthcare professionals, and health
authorities should consider plague to be a real threat. Its focal condition makes it a
regional nosological problem, and it can be expected that most cases will be among
residents of these areas. Suspected cases outside of these focal areas should be
rigorously investigated. Particular attention should be given to the events that
occurred 12 days before the onset of symptoms. These events include contact with other
suspected patients or animals from the focal areas and trips to plague regions of Brazil
or other countries in Asia, Africa, and South and North America where the disease also
occurs
.On evaluating any suspected cases, it is crucial to remember that plague is a focal
zoonosis. In January 2019, the press reported the occurrence of a presumed plague case
in the urban area of São Gonçalo in the State of Rio de Janeiro approximately 70 km away
from the plague area of Serra dos Órgãos
,
. The hypothesis of spillover was unlikely considering that wild rodents
primarily uphold the disease, and no plague activity was recorded among them in that
area.Importing and trade of animals require special attention. These growing and profitable
activities are responsible for the occurrence of plague both in endemic and non-endemic
areas, putting staff and customers at risk
. Therefore, plague must be considered when acute febrile diseases are diagnosed
in the most diverse mammal species, which exposes owners, veterinarians, and assistants
to a high-risk situation
,
.Human-to-human transmission is another event to consider. In a focal area in Peru in
2010, a physician and a medical student were infected with Y. pestis
after they provided care for a patient whose initial diagnosis was community-acquired
pneumonia or influenza, without the use of adequate respiratory protection. They were
admitted to the intensive care unit, and the 21-year-old medical student died
. During an outbreak in Madagascar, 2,417 cases occurred from August to November
of 2017, of which 77% presented the pneumonic form, and 81 cases occurred in health
professionals
.An accurate diagnosis of plague is still challenging. The predominant clinical
presentation of the disease is the flea-transmitted bubonic form, which is characterized
by the presence of buboes or painful adenitis. The rarer pneumonic form is transmitted
from person-to-person via respiratory droplets, which causes in cough, dyspnea, chest
pain, and mucus/bloody sputum. In the primary septicemic form without apparent buboes,
the patients present with fever, chills, headache, generalized body aches, weakness,
anorexia, hypotension, and fast/irregular pulse
.Bubonic plague can be clinically mistaken for other diseases. These diseases include
sexually transmitted infections, toxoplasmosis, cytomegalovirus, acute histoplasmosis,
tularemia, neoplasm, ruptured hernia, rickettsioses, typhoid fever, sepsis, and other
processes involving fever and lymphadenopathy. It is worth emphasizing that lymphangitis
does not occur in the plague, and the buboes are extremely painful. Septicemic plague
should be differentiated from bacterial septicemia and other infectious diseases of
acute onset and rapid and severe course. These infections include meningococcemia,
typhus, typhoid fever, malaria, dengue III and IV, and Rocky Mountain spotted fever.
Pneumonic plague should be distinguished from other types of pneumonia,
bronchopneumonia, and cardiopulmonary syndrome due to hantavirus. The detection of a
cavitary lesion on chest radiography may suggest tuberculosis, which can be ruled out
based on the natural history of the disease
.Distinct sample specimens should be obtained depending on the various forms of the
disease, including bubo aspirate and blood for the bubonic form and sputum for the
pneumonic plague. It is essential to collect the blood for cultures in all suspected
cases to determine the presence of Y. pestis and obtain the serum for
serological tests. Y. pestis is a gram-negative coccobacillus of the
family Enterobacteriaceae. It is categorized as a Category A bioterrorism agent
requiring level 3 biosafety. The sample collection requires disposable gloves, a
laboratory coat, and respiratory protection for biosafety level 3. The manipulation of
biological samples for the diagnosis of plague requires a level 3 containment
laboratory
,
.Since the plague cannot eradicated yet, rigorous monitoring of host and vector
populations would allow early detection of any activity in the wild. Such an approach
triggers prompt control measures, preventing the potential spread to humans.
Furthermore, it is imperative to provide continuous training to healthcare professionals
in the affected areas. The education of primary care teams should focus on early
detection and control. Secondary and tertiary care staff need to be aware of the
clinical and epidemiological features for a precise therapeutic decision as some cases
may evolve unfavorably or have clinical presentations that require special care.
Authors: Luis F Donaires; Manuel Céspedes; Pedro Valencia; Juan Carlos Salas; María E Luna; Alex Castañeda; Víctor Peralta; César Cabezas; Paul E Pachas Journal: Rev Peru Med Exp Salud Publica Date: 2010-09
Authors: Paula A Schaffer; Stephanie A Brault; Connor Hershkowitz; Lauren Harris; Kristy Dowers; Jennifer House; Tawfik A Aboellail; Paul S Morley; Joshua B Daniels Journal: Emerg Infect Dis Date: 2019-04 Impact factor: 6.883
Authors: Diego Leandro Reis da Silva Fernandes; Elainne Christine de Souza Gomes; Matheus Filgueira Bezerra; Ricardo José de Paula Souza E Guimarães; Alzira Maria Paiva de Almeida Journal: PLoS One Date: 2021-04-02 Impact factor: 3.240
Authors: Matheus Filgueira Bezerra; Camila Cavalcanti Xavier; Alzira Maria Paiva de Almeida; Christian Robson de Souza Reis Journal: PLoS Negl Trop Dis Date: 2022-05-12